Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H22N2O3 |
Molecular Weight | 326.3896 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(C(O)=O)C(=O)N(NC1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=FLWFHHFTIRLFPV-UHFFFAOYSA-N
InChI=1S/C19H22N2O3/c1-2-3-14-17(19(23)24)18(22)21(16-12-8-5-9-13-16)20-15-10-6-4-7-11-15/h4-13,17,20H,2-3,14H2,1H3,(H,23,24)
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.rosheta.com/en/2222/octomotol
110 mg twice daily
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
M01AB07
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
||
|
WHO-VATC |
QM01AB07
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB05968MIG
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
Bumadizone
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
ATD81G944M
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
DTXSID0022698
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
DB13286
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
222-710-1
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
2847
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
3583-64-0
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
C100233
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
C72113
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
m2758
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | Merck Index | ||
|
76119
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
100000088459
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
19847
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | RxNorm | ||
|
426
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
19161
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105456
Created by
admin on Fri Dec 15 16:20:33 GMT 2023 , Edited by admin on Fri Dec 15 16:20:33 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)